Back to Research Hub
Amgen Inc.
AMGN
$344.56-1.17 (-0.34%)
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas.
StreetsValue research for Amgen Inc. (AMGN)
Members get the full report for Amgen Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.